Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long Covid

OMF Welcomes Alain Moreau, PhD, to our Scientific Advisory Board

Dr. Alain Moreau joins the OMF Scientific Advisory Board

OMF is honored to welcome Canadian researcher, Dr. Alain Moreau, to our Scientific Advisory Board (SAB,) which is directed by Ronald W. Davis. PhD.

“I initially decided to invite Dr. Moreau to join our ME / CFS Working Group because he demonstrated that he could take multiple novel approaches to understanding the disease. For example, he has conducted an extensive analysis of the microRNAs that can exert major controls over cell function. It is clear that his work will be very complementary to the research of other investigators.  I was pleased to invite him to join the OMF Scientific Advisory Board. It extends our international collaboration for solving ME / CFS.”

Ron Davis, PhD

Recently, Dr. Moreau was appointed Director of the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis Research Network, a national research network funded by the Canadian Institute of Health Research.

Additionally, a generous Canadian family made an anonymous, designated gift to OMF Canada of $1.2 million over two years to support Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) research undertaken in Dr. Moreau’s Montreal-based laboratory.

“The support of Open Medicine Foundation Canada arrives at a critical time for my team, and we wish to thank all of you who are contributing to our research efforts to decipher the ME / CFS enigma. I truly believe that we are at the brink of a breakthrough. Still, success will come only by working in a collaborative manner, not in silos, because together we can achieve the excellence necessary to end ME / CFS”.

Alain Moreau PhD

Welcome, Dr. Moreau, to OMF’s global collaboration team.

Learn more about Dr. Moreau

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.

How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669